Rigetti Computing is navigating a punishing stretch that combines a sector-wide rotation out of high-risk tech with intensifying scrutiny of its own valuation metrics. Shares closed the week at €12.36, a loss of nearly 15 percent over five sessions, extending a monthly retreat of 29.85 percent. Despite a modest uptick of 0.21 percent on Friday, the broader picture is one of a stock that has seen its pandemic-era hype systematically deflate.
The pain is not unique to Rigetti. Peers IonQ and D-Wave have all fallen 60 to 76 percent from their 52-week highs, and the group shed a further 17 to 20 percent in the past week alone. Analysts at Bank of America, speaking at the Quantum.Tech World Conference, framed the problem as structural: the industry lacks commercially relevant algorithms and fault-tolerant hardware to deliver a genuine quantum advantage. The Philadelphia Semiconductor Index has slumped more than 19 percent from its June peak, adding to the gravitational pull on heavily valued quantum names.
For Rigetti, the valuation question is particularly pointed. A recent analysis by Simply Wall St tested the stock against six different undervaluation metrics and found not a single positive signal. The company’s price-to-book ratio stands at roughly 8.0, well above the semiconductor sector average of 5.1 and the pure-play quantum peer average of 4.5. With Rigetti still posting operating losses — a loss of $26.0 million on revenue of just $4.4 million in the quarter ended March 31, 2026 — the premium investors are paying for future promise looks stretched.
The deal that once lent credibility to that promise — a contract to supply a 108-qubit system to India’s Centre for Development of Advanced Computing — remains on the books, but analysts now question whether it can justify the current price multiple. The euphoria that followed a non-binding announcement of potential US government funding of $100 million has also dissipated. Traders have rotated out of positions, refocusing on fundamentals that show declining annual revenue and heavy cash consumption.
Should investors sell immediately? Or is it worth buying Rigetti?
Not everyone is bearish. Rigetti’s balance sheet provides a genuine buffer: liquid assets and marketable securities totaled $569.0 million at the end of the first quarter, giving the company runway to continue developing new chips and systems. The cash position is a key differentiator in a sector where many peers are burning through capital at an even faster clip.
Chart indicators reflect the tension. The 14-day relative strength index sits at 31.5, flirting with oversold territory and tempting bargain hunters. Yet the stock’s 30-day annualized volatility has topped 75 percent, underscoring the extreme nervousness around the name. From its 52-week high of €50.30 reached in mid-October, Rigetti has lost 75.44 percent, leaving it just 12.33 percent above the March low of €11.00. The 75 percent-plus volatility reading suggests the swings are far from over.
The gap between narrative and numbers remains wide. While Rigetti’s cash pile and contract wins offer tangible support, the valuation premium relative to its sector and quantum peers means the stock has little room for error. Until the company can demonstrate revenue growth that justifies the multiple — or until the market resets expectations closer to industry norms — the shares will likely continue to swing sharply with every sector headline and operational update.
Ad
Rigetti Stock: Buy or Sell?! New Rigetti Analysis from July 18 delivers the answer:
The latest Rigetti figures speak for themselves: Urgent action needed for Rigetti investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 18.
Rigetti: Buy or sell? Read more here...










